Brief: Sprint Bioscience Gets Positive Partial Results In Ongoing Preclinical Study
14/11/2022 08:34
Nov 14 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* SPRINT BIOSCIENCE AB - RECEIVED POSITIVE PARTIAL RESULTS
IN
ONGOING PRECLINICAL PROOF-OF-CONCEPT STUDY CONDUCTED IN
COMPANY'S NASH PROGRAM
Source text for Eikon: ID:nMFN4QQpHk
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln